Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0090
-0.0005 (-5.26%)
Apr 17, 2026, 2:54 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 34.9 million as of April 17, 2026. Its market cap has increased by 120.22% in one year.
Market Cap
34.90M
Enterprise Value
30.25M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has decreased from 39.36M to 34.90M, a decrease of -11.33%. That is a compound annual growth rate of -0.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 34.90M | 5.56% |
| Dec 31, 2025 | 33.06M | 317.27% |
| Dec 31, 2024 | 7.92M | -28.57% |
| Dec 29, 2023 | 11.09M | -59.76% |
| Dec 30, 2022 | 27.57M | 0.10% |
| Dec 30, 2021 | 27.54M | -40.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 70.88M |
| Neurizon Therapeutics | 60.96M |
| Imugene | 55.34M |
| Prescient Therapeutics | 54.68M |
| Entropy Neurodynamics | 45.28M |
| Proteomics International Laboratories | 41.30M |
| NeuroScientific Biopharmaceuticals | 38.25M |
| EZZ Life Science Holdings | 37.65M |